17-7289579-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015982.4(YBX2):c.995C>T(p.Ala332Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,612,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015982.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
YBX2 | NM_015982.4 | c.995C>T | p.Ala332Val | missense_variant | 7/9 | ENST00000007699.10 | NP_057066.2 | |
YBX2 | XM_017024713.3 | c.1040C>T | p.Ala347Val | missense_variant | 8/10 | XP_016880202.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
YBX2 | ENST00000007699.10 | c.995C>T | p.Ala332Val | missense_variant | 7/9 | 1 | NM_015982.4 | ENSP00000007699.5 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151972Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000210 AC: 5AN: 238618Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 130180
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460284Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726398
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151972Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74256
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.995C>T (p.A332V) alteration is located in exon 7 (coding exon 7) of the YBX2 gene. This alteration results from a C to T substitution at nucleotide position 995, causing the alanine (A) at amino acid position 332 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at